UK patients suffering from severe diagnoses such as quadriplegia or vision loss can now apply to take part in future clinical trials for brain-computer interface implants by Elon Musk's Neuralink.

Related Keywords

Canada , United Kingdom , Elon Musk , Noland Arbaugh , Drug Administration , Wall Street Journal ,